You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial
|
|---|---|
| Published in |
Frontiers in Pharmacology, January 2023
|
| DOI | 10.3389/fphar.2022.1096853 |
| Pubmed ID | |
| Authors |
Francesco Di Pierro, Amjad Khan, Somia Iqtadar, Sami Ullah Mumtaz, Muhammad Nabeel Akbar Chaudhry, Alexander Bertuccioli, Giuseppe Derosa, Pamela Maffioli, Stefano Togni, Antonella Riva, Pietro Allegrini, Martino Recchia, Nicola Zerbinati |
X Demographics
The data shown below were collected from the profiles of 90 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 10 | 11% |
| France | 8 | 9% |
| Canada | 2 | 2% |
| United Kingdom | 2 | 2% |
| Italy | 2 | 2% |
| New Zealand | 1 | 1% |
| Curaçao | 1 | 1% |
| Netherlands | 1 | 1% |
| Iceland | 1 | 1% |
| Other | 2 | 2% |
| Unknown | 60 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 81 | 90% |
| Practitioners (doctors, other healthcare professionals) | 4 | 4% |
| Scientists | 3 | 3% |
| Science communicators (journalists, bloggers, editors) | 2 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 25 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 5 | 20% |
| Student > Bachelor | 4 | 16% |
| Student > Ph. D. Student | 2 | 8% |
| Lecturer | 1 | 4% |
| Student > Master | 1 | 4% |
| Other | 3 | 12% |
| Unknown | 9 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 20% |
| Agricultural and Biological Sciences | 3 | 12% |
| Medicine and Dentistry | 2 | 8% |
| Environmental Science | 1 | 4% |
| Biochemistry, Genetics and Molecular Biology | 1 | 4% |
| Other | 4 | 16% |
| Unknown | 9 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 115. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 April 2024.
All research outputs
#372,913
of 25,760,414 outputs
Outputs from Frontiers in Pharmacology
#141
of 19,997 outputs
Outputs of similar age
#8,935
of 479,761 outputs
Outputs of similar age from Frontiers in Pharmacology
#3
of 928 outputs
Altmetric has tracked 25,760,414 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 19,997 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 479,761 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 928 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.